Released Mar 1, 2022, after the close
10-K filed Mar 1, 2022, 60 days after period end · 0001636422-22-000011
Q4 2021 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$64.72M$64.72M derived+21.5% vs Q4 2020+4.8% vs Q3 2021
Net Income-$48.99M-$48.99M derivedN/M vs Q4 2020N/M vs Q3 2021
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$44,765,000N/M
Operating Cash Flowderived-$9,775,000N/M
Free Cash Flowderived-$10,398,000N/M
Margins · derived
Operating margin-69.2%+3.9 pt vs Q4 2020
Net margin-75.7%+5.0 pt vs Q4 2020
What the release said
The release
Same quarter
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|---|---|
| Revenue | $64.72M | $53.28M | $43.50M | — |
| Net Income | -$48.99M | -$43.02M | -$14.27M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR